Ftse Mib
35.381,19
-0,08%
DAX
18.666,52
-0,32%
S&P 500
5.297,10
-0,21%
NASDAQ
16.698,32
-0,26%
Bitcoin
66.354,89
1,71%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aravive (delisted) (VSAR) Aravive (delisted) (VSAR) Notizie

VSAR

VERSARTIS, INC. (VSAR)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VSAR
DataOraFonteTitoloSimboloCompagnia
19/10/201822:14Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:VSARAravive (delisted)
17/10/201812:04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:VSARAravive (delisted)
17/10/201800:34Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:VSARAravive (delisted)
17/10/201800:07Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:VSARAravive (delisted)
16/10/201823:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:VSARAravive (delisted)
15/10/201813:00GlobeNewswire Inc.Aravive Biologics and Versartis Complete MergerNASDAQ:VSARAravive (delisted)
05/10/201822:47Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:VSARAravive (delisted)
20/09/201823:05Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:VSARAravive (delisted)
06/09/201822:22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:VSARAravive (delisted)
06/09/201815:27Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:VSARAravive (delisted)
06/09/201812:01Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:VSARAravive (delisted)
04/09/201813:04Edgar (US Regulatory)Registration Statement for Securities to Be Issued in Business Combination Transactions (s-4/a)NASDAQ:VSARAravive (delisted)
08/08/201822:25Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:VSARAravive (delisted)
08/08/201822:16Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:VSARAravive (delisted)
07/08/201822:15GlobeNewswire Inc.Versartis Reports Second Quarter 2018 Financial Results and Reviews Recent DevelopmentsNASDAQ:VSARAravive (delisted)
03/08/201823:58Edgar (US Regulatory)Securities Registration: Business Combination (s-4)NASDAQ:VSARAravive (delisted)
24/07/201822:15Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:VSARAravive (delisted)
10/07/201814:29Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:VSARAravive (delisted)
04/06/201814:00GlobeNewswire Inc.Versartis Enters into Merger Agreement with Aravive Biologics to Form a Clinical-Stage Biopharmaceutical Company Advancing In...NASDAQ:VSARAravive (delisted)
08/05/201822:15GlobeNewswire Inc.Versartis Reports First Quarter 2018 Financial ResultsNASDAQ:VSARAravive (delisted)
11/04/201812:06Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:VSARAravive (delisted)
26/03/201822:05GlobeNewswire Inc.Eyenovia Appoints Three Industry Veterans to Board of DirectorsNASDAQ:VSARAravive (delisted)
06/03/201823:29Edgar (US Regulatory)Annual Report (10-k)NASDAQ:VSARAravive (delisted)
01/03/201822:05GlobeNewswire Inc.Versartis Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Corporate UpdateNASDAQ:VSARAravive (delisted)
30/11/201714:00GlobeNewswire Inc.Report: Exploring Fundamental Drivers Behind Amerco, Caesars Entertainment, Air Products and Chemicals, Consolidated Edison, ...NASDAQ:VSARAravive (delisted)
26/10/201722:05GlobeNewswire Inc.Versartis Reports Third Quarter 2017 Financial Results and Provides Corporate UpdateNASDAQ:VSARAravive (delisted)
26/10/201722:05GlobeNewswire Inc.Versartis Hires Cowen to Assist in Evaluating Potential Strategic TransactionsNASDAQ:VSARAravive (delisted)
21/09/201722:30GlobeNewswire Inc.Versartis Announces Phase 3 VELOCITY Trial of Somavaratan in Pediatric Growth Hormone Deficiency Did Not Meet Primary Endpoin...NASDAQ:VSARAravive (delisted)
07/09/201722:05GlobeNewswire Inc.Versartis’ Twice-Monthly Somavaratan for Pediatric Growth Hormone Deficiency to be Featured in Oral and Poster Presentation...NASDAQ:VSARAravive (delisted)
05/09/201722:05GlobeNewswire Inc.Versartis Announces Expansion of Executive Leadership Team with Addition of Dr. Robert Gut as the Head of Global Clinical, M...NASDAQ:VSARAravive (delisted)
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:VSAR

La tua Cronologia

BIT
F12643
Vontobel Financial Produ...
BOV
BBASU475
BBASU475 Ex:23,22
BIT
S31354
Societe Generale Effekten
NYSE
HUN
Huntsman
AMEX
NANC
Unusual Whales Subversiv...
HITB
GSTSOLBTC
GST [Green Satoshi Token]
NASDAQ
APLT
Applied Therapeutics
BIT
BXX
ETF
COIN
RECGBP
EU
CACMN
CAC Mid 60 Net Return
AMEX
SJB
ProShares Short High Yield
HITB
RNDRBTC
Render Token
COIN
BTCHGEUR
LSE
31PB
Stand.chart.44r
ASX
LNYNA
COIN
SPRINGUSD
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network